Among the questions research teams bring to us, one comes up more than any other: what paperwork do we need before a research peptide clears customs, and does a research-use label actually protect us? Peptide import Canada decisions get murky quickly, because these compounds sit between chemical reagent, drug, and health product. This guide sets out how we approach the problem, based on what we require for our own shipments and what goes wrong when labs skip the documentation. It is practitioner guidance, not legal advice, so use it as a checklist for your compliance office.
Table of Contents
- Quick Takeaways
- How Health Canada Frames Commercial Imports
- Research-Use-Only Labeling and Why It Does Not Settle the Question
- Documents That Should Arrive With Every Shipment
- Customs Clearance and Working With a Broker
- Comparing Procurement Routes
- Building a Procurement File That Survives an Audit
- Timelines, Costs, and Common Mistakes
- Frequently Asked Questions
- References
Quick Takeaways
| Key Insight | Explanation |
|---|---|
| Classification drives everything | Your paperwork has to match what the product is and how it will be used. A research label alone does not decide the outcome. |
| Start with Health Canada's commercial import guidance | Document GUI-0117 is the reference for commercial imports. The version we reviewed is dated December 21, 2020, so check the page for updates before you rely on it. |
| Demand a lot-specific COA | A generic purity claim is not a certificate of analysis. The lot number on the certificate must match the lot number on the vial. |
| Confirm chain of custody before you order | Know who handled the material from verification to delivery, and ask for that record in writing. |
| Declare the product as a laboratory reagent | Invoices and declarations should describe the material for in vitro research, and only if that is what it will actually be used for. |
| Build the file before the box arrives | Keep purchase orders, COAs, invoices, and receiving checks together so an audit takes minutes, not weeks. |
| Domestic sourcing shortens the paper trail | Shipments that stay within Canada avoid border clearance, though you still need the same core documents. |
How Health Canada Frames Commercial Imports
The starting point for any peptide import Canada decision is Health Canada's guidance on importing and exporting health products for commercial use, document GUI-0117. It is an administrative document, and it states that it does not form part of the Food and Drugs Act. If the guidance and the Act or regulations ever conflict, the Act or regulations take precedence.
The guidance is organized by product category, and that structure matters more than most buyers expect. Its table of contents separates active pharmaceutical ingredients for human use, human drugs, natural health products, veterinary products, medical devices, and several biological categories. A research peptide does not announce which category it belongs to, so you have to work that out from the compound, its stated use, and how it is marketed.
Commercial use is the trigger
The document is written around commercial importation, meaning goods brought in as part of a business activity. Research labs buying through a company or institutional purchasing system usually fall under that lens, even though the science itself is not commercial. In practice, we treat every institutional order as commercial and document it that way from the start.
Where the non-compliant drug provisions fit
The table of contents includes a section on advance notice of importing non-compliant drugs under section A.01.044 of the Food and Drug Regulations. Read that section before you assume a compound is outside scope. Retatrutide is an investigational compound and not a marketed drug, so it deserves more scrutiny at the paperwork stage, not less. Ask your compliance office whether any advance notice applies to your specific product and presentation.
Research-Use-Only Labeling and Why It Does Not Settle the Question
Research-use-only labels are common in this market, and they are necessary, but they are not a shield. A label describes what the seller intends. Customs staff and regulators look at what the product is, how it is described, how it is sold, and whether the paperwork supports a laboratory purpose.
Our working rule is simple. If the label says research use only but the invoice, the product page, or the sales conversation says something else, the mismatch is your problem before it is anyone else's.
What a label cannot fix
A research-use statement cannot override marketing copy that suggests personal use, dosing, or wellness benefits. If a product page talks about body composition or recovery, a reviewer is likely to read the material as something other than a reagent. We keep our product descriptions to laboratory identity, purity, and handling, and we expect buyers to describe the material internally with the same discipline.
A label tells customs what you hope the product is used for. Your documents have to show what the product actually is and where it is going.
Writing your purchase description
Your purchase order should name the compound, the presentation, the intended laboratory use, and the institution receiving delivery. Vague wording such as "research sample" invites questions. A specific line, such as lyophilized retatrutide in a 10mg vial for an in vitro assay, gives the paperwork one consistent story from order to delivery.
Documents That Should Arrive With Every Shipment
Paperwork is where a clean import and a stalled one separate. At minimum, every research shipment should arrive with a batch-specific Certificate of Analysis, a clear statement of identity and purity, and records showing who handled the material. At Pepura Labs, each lot is tied to independent verification by Canadian laboratories, and orders ship with chain of custody records so you can trace the batch back through the process. You can read more about our Canadian lab testing process on our site.
Certificate of Analysis
A purity figure on a product page is not a COA. Ask for a certificate that lists the lot number, the analytical method, the measured purity, and the testing date. If the lot number on the vial does not match the certificate, stop and resolve it before the material enters your inventory.
Chain of custody and batch traceability
Chain of custody answers a simple question: who had the material, where, and when? Batch traceability links that record to the specific fill your lab receives. Together, they let an auditor follow a vial from the verification lab to your bench without relying on anyone's memory.
Pro tip: Before you place an order, ask the supplier for a sample COA and check that it names the lot, the method, and the testing laboratory. A supplier who hesitates to share one is giving you useful information.
Customs Clearance and Working With a Broker
Customs clearance is where the paperwork meets the border. The declaration has to describe the goods accurately, and that description has to match the invoice, the packing list, and the purchase order. A mismatch between those three documents causes more delays than any other issue we see, even when the product itself is compliant.
Many institutions use a licensed customs broker for regulated goods. A good broker asks about the product category before filing, not after the parcel has been held. Give them the COA, the safety data sheet where one is available, and a clear statement of laboratory purpose so the goods are classified correctly from the start.
Declaring the product accurately
Use the product's laboratory identity in every field. Do not describe it with personal-use language, dosing instructions, or consumer terms. If your purchasing system asks for a category, choose the one that matches the laboratory function and note why you chose it.
Planning for holds and information requests
Assume a hold is possible and build it into your timeline. When a shipment is held, the questions usually come back to three items: what the product is, what it is for, and who is receiving it. Write those answers down in advance and the response time drops from days to hours. Never schedule a critical reagent for a deadline without a buffer.
Comparing Procurement Routes
Most labs choose between three routes, and each one trades paperwork against speed and certainty. The right choice depends on how urgent the study is and how much documentation your compliance office will accept. The table below reflects what we see at the bench, and we are a domestic option, so weigh our perspective accordingly.
| Procurement Route | Documentation Burden | Best Fit |
|---|---|---|
| Domestic supplier with lot-specific COA and chain of custody | Low to moderate: COA, chain of custody records, and a commercial invoice | Time-sensitive studies that need traceable, Canadian-verified material |
| Cross-border purchase filed through a licensed customs broker | High: commercial import documents, broker filings, and possible holds | Institutions with established import compliance teams and longer lead times |
| Direct purchase from an overseas seller with no Canadian verification | High and unreliable: document quality varies and verification is often unavailable | Not recommended for regulated research programs |
Overseas sourcing may be permissible in some situations, but it shifts the burden of verification onto your lab. That cost is easy to underestimate until a lot fails to match its paperwork.
Where domestic sourcing wins
Domestic shipments avoid border clearance, which removes the least predictable step in the chain. You still need the same documentation, but you control it. Xpresspost delivery across Canada keeps the timeline short, and the paper trail stays within one jurisdiction.
What to ask before you order
Ask four questions. Is the COA batch-specific? Who performed the verification? Is chain of custody included with the order? Does the lot number on the vial match the paperwork? A supplier who answers all four without friction is one you can audit later.
Building a Procurement File That Survives an Audit
Most import problems are solved in the file, not at the border. A principal investigator, an auditor, or a compliance officer will eventually ask how you chose a supplier, what you received, and whether it matched the order. If you cannot answer those questions quickly, even a compliant purchase looks suspicious.
Records to keep
Keep the purchase order, supplier invoice, shipping record, lot-specific COA, chain of custody documentation, and receiving log together under one reference. Follow your institution's retention policy, which usually runs longer than the study itself. Store digital and paper copies in the same place so nothing lives only in one person's inbox.
Receiving checks and sign-off
Have the person receiving the shipment compare the lot number on each vial against the COA before the material goes into inventory. Require sign-off from the principal investigator or compliance contact for regulated purchases. A two-signature process takes minutes and prevents most of the record gaps we see in practice.
Timelines, Costs, and Common Mistakes
Timelines are where good intentions fail. A procurement request that starts two days before a deadline is almost certain to be late, especially if customs or the supplier needs to request additional documents. Build lead time into the project calendar, not into the final week.
Common mistakes we see
The most frequent mistake is ordering from a product page instead of a specification. The second is treating the COA as a formality and filing it unread. The third is letting one person hold all the knowledge of where the material came from. Each of these is cheap to fix and expensive to ignore.
Budgeting for compliance
Compliance work has real costs in staff time, broker fees where you use one, and the risk of a held shipment. Do not choose a supplier on unit price alone. A lower price that generates a week of correspondence or a rejected lot costs more than it saves.
Pro tip: Keep a one-page procurement summary for each compound that states the product identity, intended laboratory use, supplier, lot number, and where the COA is stored. When an auditor asks, you hand over one page instead of searching three inboxes.
Frequently Asked Questions
Is it legal to import research peptides into Canada?
The answer depends on the specific product, how it is classified, and how the import is documented, so no blanket yes or no is responsible. Health Canada's commercial import guidance (GUI-0117) is the starting reference, and your institution's compliance office should confirm the position for your compound before you order.
Does a research-use-only label make a peptide compliant?
No. A label describes intended use, but customs staff and regulators also look at product descriptions, marketing, invoices, and supporting documents. A label that conflicts with the rest of the paperwork creates more risk, not less.
What documents should I request with a peptide shipment?
At minimum, ask for a lot-specific Certificate of Analysis, chain of custody records, an invoice that describes the product as a laboratory reagent, and any safety data sheet the supplier has available.
Should I use a customs broker for research compounds?
For institutional buyers, a broker is often worth the cost, especially for cross-border orders. Give the broker the COA and a precise statement of laboratory purpose before filing, not after a shipment has been held.
Is domestic sourcing always easier?
It usually reduces border steps and shortens timelines, but it does not remove documentation duties. You still need traceable lot records, verified purity data, and a clear purchase description.
How long should I keep procurement records?
Follow your institution's retention policy and any funder or ethics board requirements. In practice, keep records at least as long as the study and any publication follow-up that depends on them.
Tell us about your experience with Canadian procurement and which document you wish you had requested earlier, because that answer often shapes the next version of your lab's process.